Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Folia Health

Request full access

Healthcare reimaginedwith a little help from the people who care most

Boston, United StatesFounded 2016Health Tech & Medtech

About Folia Health

Folia Health, founded in 2016 by Nell Meosky Luo and Daniel Toffling, operates a digital platform designed to systematically collect and analyze patient-generated health data. The company's creation was directly inspired by the founders' personal experiences as caregivers for family members with chronic and rare conditions. CEO Nell Meosky Luo witnessed her mother meticulously document her brother's immunodeficiency in notebooks and recognized the untapped value of this patient-level data. Similarly, Co-founder and CTO Dan Toffling, a father to a child with Down Syndrome, sought to apply his technical background to improve care quality by empowering patients and families. Luo, a Yale graduate in Public Health, and Toffling connected after she advertised for a co-founder with a technical background and firsthand understanding of managing a chronic condition.

The company's core offering is a free mobile application that enables patients and caregivers to track health observations, such as symptoms, treatments, flare-ups, and daily activities, in a structured format. This platform, which supports over 600 conditions, transforms qualitative, lived experiences into quantitative, longitudinal data known as Home-Reported Outcomes (HROs). Key features include customizable daily journals, treatment and observation logs, flexible scheduling, and a flare tracker. The generated data is visualized in graphs and reports, providing users with insights into their health trends and treatment efficacy, which can be shared with clinicians to facilitate more data-driven care.

Folia Health's business model is centered on partnerships with life science companies, including pharmaceutical and biotech firms. The company provides these partners with access to anonymized, aggregated real-world evidence derived from the platform's user data. This information is valuable for optimizing clinical trial design, developing novel endpoints, and accelerating patient-focused drug development. The platform is offered free to patients and caregivers; revenue is generated through these research collaborations. Folia Health also has a "Data Dividends" program, which compensates users with gift cards for consistently tracking and opting to share their anonymized data for research purposes.

Source: Dealroom company data

At a glance

Status
Operational
Employees
47
Open positions
4
Dealroom signal
86.3/100
Industry
Health
Sub-industry
Health Platform
Sector
Precision Medicine, Disease, Hard Tech
Client focus
B2B

Funding history

5 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES AOther financing Oct 2025 $11M $42M S3 Ventures · Crosslink Capital · Create Health Ventures ↗
DEBTDebt Jan 2021 $502K — Undisclosed —
Showing the latest 2 of 5 recorded eventsBook a demo for the full funding history →

Growth signals

Folia Health website traffic

Latest recorded traffic for Folia Health is 38K monthly website visits, up 46.2% over the last three months. Folia Health's team grew 80.8% over the past year.

Latest monthly visits38K 3-month web change+46.2% 1-year team growth+80.8%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Folia Health in the Boston ecosystem

Live from Dealroom

The Folia Health office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

13 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A4 investors entered at this stage

Other known investors9 additional known investors

  • AgeTech Collaborative from AARP
  • Bantam Group
  • CharacterVC
  • Jim Feuille
  • Launchpad Venture Group
  • MassChallenge
  • Social Starts
  • TBD Angels
  • Walnut Venture Associates
Team profiled 4 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Folia Health on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Folia Health’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.